Dishman Carbogen Amcis Limited (DCAL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.95 Billion ≈ $31.93 Million USD) by net assets (Rs63.65 Billion ≈ $688.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DCAL market cap for the company's overall valuation and market capitalisation.

Dishman Carbogen Amcis Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Dishman Carbogen Amcis Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dishman Carbogen Amcis Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their cash flow conversion efficiency. Explore Dishman Carbogen Amcis Limited (DCAL) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Medios AG
XETRA:ILM1
0.021x
Immuneering Corp
NASDAQ:IMRX
-0.053x
Young Optics Inc
TW:3504
0.021x
STEP Energy Services Ltd
TO:STEP
0.058x
Médica Sur S.A.B. de C.V
MX:MEDICAB
-0.033x
ANY Security Printing PLC
BUD:ANY
0.406x
Izertis Sa
MC:IZER
0.261x
Regional Management Corp
NYSE:RM
0.216x

Annual Cash Flow Conversion Efficiency for Dishman Carbogen Amcis Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Dishman Carbogen Amcis Limited from 2005 to 2025. View Dishman Carbogen Amcis Limited share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs58.32 Billion
≈ $630.66 Million
Rs3.75 Billion
≈ $40.58 Million
0.064x -5.70%
2024-03-31 Rs56.27 Billion
≈ $608.59 Million
Rs3.84 Billion
≈ $41.52 Million
0.068x +49.05%
2023-03-31 Rs58.10 Billion
≈ $628.29 Million
Rs2.66 Billion
≈ $28.76 Million
0.046x -28.42%
2022-03-31 Rs55.49 Billion
≈ $600.10 Million
Rs3.55 Billion
≈ $38.38 Million
0.064x -28.91%
2021-03-31 Rs56.99 Billion
≈ $616.31 Million
Rs5.13 Billion
≈ $55.44 Million
0.090x -12.14%
2020-03-31 Rs57.15 Billion
≈ $618.06 Million
Rs5.85 Billion
≈ $63.28 Million
0.102x +95.28%
2019-03-31 Rs53.79 Billion
≈ $581.73 Million
Rs2.82 Billion
≈ $30.50 Million
0.052x +18.26%
2018-03-31 Rs51.07 Billion
≈ $552.34 Million
Rs2.26 Billion
≈ $24.49 Million
0.044x -29.48%
2017-03-31 Rs48.14 Billion
≈ $520.61 Million
Rs3.03 Billion
≈ $32.73 Million
0.063x -67.24%
2016-03-31 Rs14.52 Billion
≈ $157.03 Million
Rs2.79 Billion
≈ $30.13 Million
0.192x -16.61%
2015-03-31 Rs12.42 Billion
≈ $134.30 Million
Rs2.86 Billion
≈ $30.91 Million
0.230x -19.70%
2014-03-31 Rs12.02 Billion
≈ $130.01 Million
Rs3.45 Billion
≈ $37.26 Million
0.287x +120.10%
2013-03-31 Rs10.55 Billion
≈ $114.06 Million
Rs1.37 Billion
≈ $14.85 Million
0.130x -21.25%
2012-03-31 Rs9.29 Billion
≈ $100.45 Million
Rs1.54 Billion
≈ $16.61 Million
0.165x -28.31%
2011-03-31 Rs8.79 Billion
≈ $95.08 Million
Rs2.03 Billion
≈ $21.93 Million
0.231x -40.14%
2010-03-31 Rs7.84 Billion
≈ $84.81 Million
Rs3.02 Billion
≈ $32.68 Million
0.385x +105.98%
2009-03-31 Rs7.04 Billion
≈ $76.18 Million
Rs1.32 Billion
≈ $14.25 Million
0.187x +120.69%
2008-03-31 Rs5.73 Billion
≈ $62.02 Million
Rs486.09 Million
≈ $5.26 Million
0.085x -36.93%
2007-03-31 Rs3.18 Billion
≈ $34.39 Million
Rs427.32 Million
≈ $4.62 Million
0.134x +64.50%
2006-03-31 Rs1.89 Billion
≈ $20.39 Million
Rs154.02 Million
≈ $1.67 Million
0.082x +151.73%
2005-03-31 Rs1.47 Billion
≈ $15.91 Million
Rs-232.28 Million
≈ $-2.51 Million
-0.158x --

About Dishman Carbogen Amcis Limited

NSE:DCAL India Biotechnology
Market Cap
$289.13 Million
Rs26.73 Billion INR
Market Cap Rank
#15105 Global
#761 in India
Share Price
Rs170.52
Change (1 day)
+5.19%
52-Week Range
Rs129.97 - Rs314.40
All Time High
Rs389.62
About

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more